US Patent 7499847 Crystalline VAP-1 and uses thereof

Patent 7499847 was granted and assigned to Biotie Therapies on March, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 17 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 17 Sep, 2023

Edits made to:

Infobox (+11 properties)

Infobox

Patent Inventor Names

Annu Söderholm0

David Smith0

Heidi Kidron0

Lenita Viitanen0

Marjo Pihlavisto0

Mark Johnson0

Olli Pentikäinen0

Tiina Salminen0

Tomi Airenne0

Tommi Nyrönen0

Yvonne Nymalm-Rejström0

Edits on 15 Sep, 2023

"Add patent abstract"

Golden AI

edited on 15 Sep, 2023

Edits made to:

Article (+412 characters)

Article

Patent abstract

The present invention relates to crystalline vascular adhesion protein-1 (VAP-1) and in particular to methods for the use of structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design and production, as well as screening assays for detection of same. The invention further relates to inhibitors identified by the assays according to the present invention.

Edits on 21 Jul, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 21 Jul, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=074998470

Edits on 19 May, 2023

"Remove leading 0 from patent number"

Golden AI